As little as one year off the drug was more than enough for study participants to lose benefits cultivated over years of continuous treatment
10.1056/NEJMoa1411892 117
Has been described as not economically attractive by the Canadian Journal of Cardiology (41) Only approved for type 2 diabetic and obese patients Co Authors : References (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41)
Wang TT, Yu LL, Zheng JM, Han XY, Jin BY, Hua CJ, et al
Consistent dosing also helps your brain and gut adapt to tirzepatide's effects, deepening appetite suppression over time
A few even say that lowering food noise is a good enough reason to take the medicine even without weight loss